Obesity: What’s Old, What’s New and How We Manage It: An Integrated Approach in Pharmacy Practice

  • Ângelo Jesus
    Centro de Investigação em Saúde e Ambiente. Escola Superior de Saúde. Instituto Politécnico do Porto, Portugal acj[at]ess.ipp.pt
  • Referencias
  • Cómo citar
  • Del mismo autor
  • Métricas
1. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402-24.

2. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.

3. González Jiménez E. Obesity: Etiologic and pathophysiological analysis. Endocrinología y Nutrición (English Edition). 2013;60(1).

4. Clarke W, Dasgupta A. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. 2016.

5. Lorico S, Colton B. Medication management and pharmacokinetic changes after bariatric surgery. Vol. 66, Canadian Family Physician. 2020.

6. Son JW, Kim S. Comprehensive review of current and upcoming anti-obesity drugs. Diabetes and Metabolism Journal. 2020; 44.

7. Kosmalski M, Deska K, Bąk B, Różycka-Kosmalska M, Pietras T. Pharmacological Support for the Treatment of Obesity—Present and Future. Vol. 11, Healthcare (Switzerland). 2023.
Jesus, Ângelo. (2023). Obesity: What’s Old, What’s New and How We Manage It: An Integrated Approach in Pharmacy Practice. FarmaJournal, 8(2), 45–46. https://doi.org/10.14201/fj2023824546

Downloads

Download data is not yet available.
+